Anti-NMDA Receptor Encephalitis

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• Anti-NMDA Receptor Encephalitis is a B-cell-mediated autoimmune encephalitis characterized by the production of pathogenic immunoglobulin G (IgG) antibodies that target the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor on neurons.
• Receptor Internalization and Synaptic Failure: At the cellular level, the binding of these pathogenic IgG antibodies triggers the internalization of NMDA receptors. This progressive loss of cell-surface NMDA receptors impairs synaptic currents, leading to severe neuropsychiatric dysfunction, complex movement disorders, autonomic instability, and seizures.
• Tumor-Induced Molecular Mimicry: The initial antigen exposure leading to antibody production is strongly associated with an underlying ovarian teratoma in 30% to 60% of cases. This occurs due to molecular mimicry, wherein the patient's immune system mounts a defense against neuronal tissue antigens expressed within the teratoma, inadvertently targeting identical NMDA receptors in the central nervous system.
• Post-Infectious Delayed Autoimmunity: Alternatively, the autoimmune cascade can be triggered weeks (typically 2 to 3 weeks) following an initial infection with herpes simplex virus (HSV) encephalitis. This delayed, post-viral immune response mimics the initial viral infection but is driven entirely by the secondary production of anti-NMDA receptor antibodies.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Resuscitation and Airway Support: Immediately assess airway patency, the patient's ability to clear oral secretions, and airway stability. If the patient exhibits respiratory compromise, severe bulbar dysfunction, or refractory status epilepticus, proceed with endotracheal intubation using standard rapid sequence intubation (RSI) protocols. If elevated intracranial pressure (ICP) is suspected, keep the head of the bed elevated to 30°.
• The Point-of-Care Glucose Rule: Perform an immediate fingerstick blood glucose check to rapidly rule out and correct hypoglycemia, which is an easily treatable mimic of altered mental status and seizures.
• Immediate Empiric Antimicrobial Resuscitation: Because anti-NMDA receptor encephalitis initially presents as an undifferentiated meningoencephalitis, patients must be treated empirically for infectious causes immediately upon arrival. Administer:
• Ceftriaxone: 2,000 mg IV prior to computed tomography (CT) imaging.
• Acyclovir: 10 mg/kg IV (every 8 hours) to cover for herpes simplex virus (HSV) encephalitis pending CSF PCR results.
• Seizure Management: Manage active seizures promptly with first-line benzodiazepines:
• Lorazepam: 2 to 8 mg IV push over 1–2 minutes. Alternatively, use weight-based dosing at 0.1 mg/kg IV (maximum dose 8 mg).
• Midazolam: 10 mg IV or IM.
• Diazepam: 10 mg IV push over 1–2 minutes (avoid intramuscular diazepam due to erratic absorption).
• Maintenance/Refractory Agents: If seizures persist, utilize valproate, levetiracetam, or carbamazepine.
• First-Line Immunotherapy (Initiated empirically in consultation with neurology upon high clinical suspicion, without waiting for antibody confirmation):
• Corticosteroids: High-dose intravenous methylprednisolone 1 g/day IV for 3 to 5 days.
• Intravenous Immune Globulin (IVIG): 2 g/kg total dose divided as 0.4 g/kg/day for 5 consecutive days.
• Plasmapheresis (Plasma Exchange): A course of 5 to 7 exchanges over approximately 2 weeks to actively clear pathogenic antibodies from systemic circulation.
• Note: These first-line regimens may be administered in combination.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

Top Encephalitis Mimics

1. Herpes Simplex Virus (HSV) Encephalitis: Classically presents with fever, headache, altered consciousness, and seizures, with a specific predilection for the temporal lobes leading to acute psychosis or behavioral changes.
2. Primary Psychiatric Disorders (e.g., Schizophrenia / Acute Psychotic Episode): Presents with delusions, hallucinations, and agitation, but lacks focal dyskinesias, autonomic instability, and cerebrospinal fluid (CSF) inflammatory markers.
3. Other Autoimmune Encephalitides (e.g., Lupus Cerebritis): Presents with acute neuropsychiatric changes, confusion, and seizures in patients with systemic lupus erythematosus (SLE).
4. Neuroleptic Malignant Syndrome (NMS): Characterized by the tetrad of altered mental status, severe muscular rigidity, hyperthermia, and autonomic instability (CPK >1000 IU/mL). Note that anti-NMDA patients are at highly elevated risk of developing NMS if treated with antipsychotics.
5. Exogenous Drug Intoxication: Delirium and hallucinations caused by anticholinergic or sympathomimetic agents.

Prioritized Diagnostic Workup Strategy

• Point-of-Care Bedside Glucose: Checked immediately at triage to rule out hypoglycemia.
• Lumbar Puncture (LP): Perform a lumbar puncture to obtain CSF for cell count, Gram stain, protein, glucose, and viral PCR (specifically HSV PCR).
• Indirect Immunofluorescence Antibody Panel: Send-out testing for anti-NMDA receptor IgG antibodies detected in both serum AND CSF (CSF is highly sensitive and diagnostic).
• Screening for Ovarian Teratoma: Because of the strong association with teratomas in up to 60% of cases, obtain a pelvic/abdominal ultrasound or CT scan to evaluate for an adnexal mass.
• Standard Stroke and Encephalitis Labs: Complete blood count, comprehensive metabolic panel, coagulation studies, pregnancy testing, and serum toxicology.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

Standard ECG Visual Checklist

• Autonomic Instability Screening: Check for extreme sinus tachycardia, sinus bradycardia, or labile fluctuations in heart rate secondary to central autonomic disruption.
• Syncope/Arrest Mimic Exclusion: Obtain a 12-lead ECG in all patients presenting with first-time seizures or syncope to rule out cardiogenic etiologies (e.g., prolonged QT, Brugada syndrome, or ischemia).

Point-of-Care Ultrasound (POCUS) Findings

• Pelvic/Transabdominal Assessment: Scan the pelvis of young female patients to screen for a complex cystic and solid adnexal mass containing hyperechoic foci, representing an ovarian teratoma.

Neuroimaging Visual Checklist

• Non-contrast Head CT: Primarily used as the initial study of choice to rule out acute hemorrhagic stroke, mass effect, or structural space-occupying mimics. In anti-NMDA receptor encephalitis, the CT is classically normal or nonspecific.
• Brain MRI (with and without contrast):
• HSV Encephalitis Mimic: Look for increased T2/FLAIR signal intensity in the temporal lobes bilaterally or unilaterally.
• PRES Mimic: Look for symmetrical vasogenic edema, typically localized in the bilateral parieto-occipital regions.
• Encephalitis Presentation: In anti-NMDA receptor encephalitis, the MRI may be completely normal early in the course of the disease.
• CT Venography (CTV) / MR Venography (MRV): Rule out cerebral venous thrombosis (CVT), which presents with headache, lethargy, and focal deficits crossing typical arterial distributions.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

Diagnostic Criteria for Anti-NMDA Receptor Encephalitis

• Serological and CSF IgG Confirmation: Definitive diagnosis requires the detection of immunoglobulin G (IgG) antibodies against the NR1 subunit of the NMDA receptor in both the serum AND CSF utilizing indirect immunofluorescence.

Delirium and Mental Status Screening Guidelines

• Delirium Triage Screen (DTS) and brief Confusion Assessment Method (bCAM): Standardized, validated bedside tools designed for the rapid identification and confirmation of delirium or acute confusional states in the ED.
• Glasgow Coma Scale (GCS): Standard 15-point scale used to quantitatively score and trend alterations in arousal and conscious content.
• Richmond Agitation Sedation Scale (RASS): Utilized to evaluate and score the depth of sedation or severity of agitation (scoring from -5 to +4).

Beers Criteria for Medication Avoidance

• Anticholinergic Restriction: In patients presenting with altered mental status or delirium, strictly avoid inappropriate medications on the Beers list (e.g., promethazine, diphenhydramine, hydroxyzine, and amitriptyline). These agents carry a heavy anticholinergic burden that can trigger or catastrophically worsen delirium.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

Deadly Cognitive Traps & Trainee Pitfalls

• Psychiatric Anchoring: Prematurely closing on a primary psychiatric diagnosis (e.g., schizophrenia) in a young female with no prior psychiatric history who presents with acute psychiatric symptoms (delusions, hallucinations, agitation, mania).
• Delaying Therapy for Antibody Confirmation: Deferring first-line immunosuppressive therapy (high-dose methylprednisolone, IVIG) while waiting for the results of the send-out anti-NMDA receptor antibody panel.
• Failing to Cover for Infectious Mimics: Neglecting to empirically administer ceftriaxone and acyclovir 10 mg/kg IV in a crashing encephalopathic patient before cerebrospinal fluid PCR results return.
• Aggressive Antipsychotic Administration: Managing severe behavioral agitation or psychosis with typical or atypical antipsychotics (such as haloperidol). In anti-NMDA receptor encephalitis, this carries an extremely high risk of triggering Neuroleptic Malignant Syndrome (NMS) or severe extrapyramidal symptoms.

Mandatory Critical Actions

• Obtain and review a bedside fingerstick glucose immediately upon arrival for any patient presenting with altered mental status or seizures.
• Empirically treat for bacterial meningitis and HSV encephalitis with ceftriaxone and acyclovir 10 mg/kg IV in all suspected cases of acute encephalitis pending PCR confirmation.
• Stop the administration of antipsychotics immediately if the patient exhibits signs of rigidity, autonomic instability, or hyperthermia.
• Initiate pelvic ultrasound or pelvic CT screening to actively search for an ovarian teratoma once the diagnosis of anti-NMDA receptor encephalitis is clinically suspected.

7. MCQ MASTERCLASS (Written Exam Tips)

High-Yield Exam "Buzzwords" and Associations

• "NR1 Subunit": The specific receptor subunit targeted by pathogenic B-cell-mediated IgG antibodies.
• "Young Female, 25-35 years old": The classic patient demographic, exhibiting a 4:1 female-to-male ratio.
• "Ovarian Teratoma": Associated tumor identified in 30% to 60% of cases; tumor resection is mandatory for clinical recovery.
• "Orofacial Dyskinesias": Uncontrolled, involuntary lip-smacking, tongue protruding, and jaw movements characterizing the hyperkinetic phase of the disease.
• "Post-HSV Trigger": Presentation of autoimmune encephalitis occurring 2 to 3 weeks after an initial herpes simplex encephalitis infection.

Differentiating Common Distractors

• Distractor: Initiating haloperidol to manage acute agitation or psychotic behavior.
• Correction: Antipsychotics are highly dangerous in anti-NMDA receptor encephalitis due to the extreme risk of triggering Neuroleptic Malignant Syndrome (NMS). Agitation and catatonia must be treated with high-dose benzodiazepines (or ECT).
• Distractor: Excluding the diagnosis because the serum antibody panel is negative.
• Correction: Serum testing alone is insufficient. Anti-NMDA receptor IgG antibodies must be tested in both serum AND CSF via indirect immunofluorescence, as CSF is highly sensitive and definitive.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

Communication Pearls & Initial Script

• "As this patient arrives with altered mental status and ongoing seizures, I am placing them in a monitored resuscitation bay and actively securing the airway, breathing, and circulation."
• "I will state clearly to my team: 'My immediate priorities are to obtain an emergent bedside point-of-care glucose to rule out hypoglycemia, secure intravenous access, and place the patient on a cardiac monitor'."

Mandatory Physical Exam Phrasing

• "I am performing a focused neurological examination, calculating the Glasgow Coma Scale (GCS) score, and screening for signs of autonomic instability by closely monitoring for labile blood pressure, heart rate, and temperature fluctuations."
• "I am specifically performing a detailed psychiatric and cranial nerve assessment, looking closely for orofacial or lingual dyskinesias such as involuntary lip-smacking, jaw grimacing, or choreoathetosis."

Smooth Articulation of Management Steps

• "Because this young female has a viral prodrome followed by acute psychiatric symptoms and movement disorders, I have a high clinical suspicion for anti-NMDA receptor encephalitis. However, I must aggressively rule out life-threatening infectious mimics."
• "I will perform an emergent lumbar puncture to evaluate the CSF. Prior to head CT and LP, I will empirically administer ceftriaxone 2 g IV and acyclovir 10 mg/kg IV to cover for bacterial meningitis and herpes simplex encephalitis."
• "I will send CSF and serum samples for indirect immunofluorescence testing for anti-NMDA receptor IgG antibodies."
• "Because clinical suspicion is high and antibody results are send-outs, I will not delay definitive treatment. In consultation with neurology, I will empirically initiate first-line immunotherapy with high-dose intravenous methylprednisolone 1 g/day for 3 to 5 days and IVIG 2 g/kg total over 5 days."
• "To identify and treat the underlying trigger, I will order a pelvic ultrasound to screen for an ovarian teratoma, as surgical resection is a critical component of first-line therapy."
• "I will manage active seizures with intravenous lorazepam and admit this patient to the Intensive Care Unit (ICU) for continuous EEG monitoring, airway protection, and close neurocritical care."